New Consumer Health in Greece View larger

Consumer Health in Greece

M00011952

New product

In stock

$2,650.00

More info

Description

The Greek consumer health market is poised to record its first decline in total current value sales for several years in 2021, with many product categories also expected to see volume sales slow or contract. This is partly the result of widespread stockpiling and panic buying that occurred in response to the outbreak of COVID-19 in early 2020, as many households have yet to exhaust supplies built up at this time. Demand for multiple product types has been further subdued by changes in consumer b...

Euromonitor International's Consumer Health in Greece report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

Get a detailed picture of the Consumer Health market; Pinpoint growth sectors and identify factors driving change; Understand the competitive environment, the market's major players and leading brands; Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
Product Code: CHGR

TABLE OF CONTENTS

List Of Contents And Tables

EXECUTIVE SUMMARY

Consumer health in 2021: The big picture 2021 key trends Competitive landscape Retailing developments What next for consumer health?

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021 Table 2 Life Expectancy at Birth 2016-2021

MARKET DATA

Table 3 Sales of Consumer Health by Category: Value 2016-2021 Table 4 Sales of Consumer Health by Category: % Value Growth 2016-2021 Table 5 NBO Company Shares of Consumer Health: % Value 2017-2021 Table 6 LBN Brand Shares of Consumer Health: % Value 2018-2021 Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021 Table 8 Distribution of Consumer Health by Format: % Value 2016-2021 Table 9 Distribution of Consumer Health by Format and Category: % Value 2021 Table 10 Forecast Sales of Consumer Health by Category: Value 2021-2026 Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026

APPENDIX

OTC registration and classification Vitamins and dietary supplements registration and classification Self-medication/self-care and preventive medicine Switches

DISCLAIMER

DEFINITIONS

SOURCES

Summary 1 Research Sources

ANALGESICS IN GREECE

KEY DATA FINDINGS

2021 DEVELOPMENTS

Previous stockpiling and COVID-19 prevention measures curb overall demand Reversal of fortunes for acetaminophen and ibuprofen in 2021 COVID-19 fallout discourages price increases and new product development

PROSPECTS AND OPPORTUNITIES

Maturity will temper further expansion of analgesics Ibuprofen expected to grow fastest, but acetaminophen will remain most popular Chemists/pharmacies will continue to dominate analgesics distribution

CATEGORY DATA

Table 12 Sales of Analgesics by Category: Value 2016-2021 Table 13 Sales of Analgesics by Category: % Value Growth 2016-2021 Table 14 NBO Company Shares of Analgesics: % Value 2017-2021 Table 15 LBN Brand Shares of Analgesics: % Value 2018-2021 Table 16 Forecast Sales of Analgesics by Category: Value 2021-2026 Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN GREECE

KEY DATA FINDINGS

2021 DEVELOPMENTS

Measures to curb spread of COVID-19 suppress demand in 2021 New law on antibiotics benefits OTC products for cough, cold and flu relief Vian's Depon Cold & Flu continues to gain ground

PROSPECTS AND OPPORTUNITIES

Habits adopted during the pandemic will continue to affect demand Greater caution around antibiotic use bodes well for OTC cough and cold remedies Competitive pressures set to intensify over the forecast period

CATEGORY DATA

Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021 Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021 Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021 Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021 Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026 Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026

DIGESTIVE REMEDIES IN GREECE

KEY DATA FINDINGS

2021 DEVELOPMENTS

Impact of COVID-19 continues to shape category performances in 2021 Demand for some product types hampered by preventive digestive health practices Penetration of OTC digestive remedies limited by UTC sales of Rx products

PROSPECTS AND OPPORTUNITIES

Preventive digestive health trend will continue to restrict volume growth potential Shift to more natural solutions will temper recovery of motion sickness remedies UTC sales of Rx brands set to remain a major challenge for OTC products

CATEGORY DATA

Table 24 Sales of Digestive Remedies by Category: Value 2016-2021 Table 25 Sales of Digestive Remedies by Category: % Value Growth 2016-2021 Table 26 NBO Company Shares of Digestive Remedies: % Value 2017-2021 Table 27 LBN Brand Shares of Digestive Remedies: % Value 2018-2021 Table 28 Forecast Sales of Digestive Remedies by Category: Value 2021-2026 Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2021-2026

DERMATOLOGICALS IN GREECE

KEY DATA FINDINGS

2021 DEVELOPMENTS

Antipruritics benefits from frequent hand washing and use of hand sanitisers Antiparasitics/lice and cold sore treatments worst affected by COVID-19 in 2021 Herbal/traditional varieties and premium products continue to gain popularity

PROSPECTS AND OPPORTUNITIES

UTC sales of Rx brands will limit volume growth prospects Further gains likely for herbal/traditional brands Chemists/pharmacies set to remain the dominant distribution channel

CATEGORY DATA

Table 30 Sales of Dermatologicals by Category: Value 2016-2021 Table 31 Sales of Dermatologicals by Category: % Value Growth 2016-2021 Table 32 NBO Company Shares of Dermatologicals: % Value 2017-2021 Table 33 LBN Brand Shares of Dermatologicals: % Value 2018-2021 Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2018-2021 Table 35 Forecast Sales of Dermatologicals by Category: Value 2021-2026 Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026

NRT SMOKING CESSATION AIDS IN GREECE

KEY DATA FINDINGS

2021 DEVELOPMENTS

Competition from alternatives and lack of innovation inhibit demand Nicorette continues to consolidate its already dominant position Chemists/pharmacies remains the sole distribution channel for NRT products

PROSPECTS AND OPPORTUNITIES

Limited prospects for expansion will deter new product development NRT gum set to remain by far the most popular product type No changes in distribution expected

CATEGORY INDICATORS

Table 37 Number of Smokers by Gender 2016-2021

CATEGORY DATA

Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021 Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021 Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2017-2021 Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2018-2021 Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2021-2026 Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2021-2026

SLEEP AIDS IN GREECE

KEY DATA FINDINGS

2021 DEVELOPMENTS

Demand remains robust but slows as impact of COVID-19 starts to subside Investment in innovation and promotional activities increases GR Sarantis maintains leading position despite growing competition

PROSPECTS AND OPPORTUNITIES

Increased consumer awareness of sleep aids should temper declining trend Competition set to intensify as more brands vie for shares in a shrinking category Growing use of alternative product types will continue to weaken demand

CATEGORY DATA

Table 44 Sales of Sleep Aids: Value 2016-2021 Table 45 Sales of Sleep Aids: % Value Growth 2016-2021 Table 46 NBO Company Shares of Sleep Aids: % Value 2017-2021 Table 47 LBN Brand Shares of Sleep Aids: % Value 2018-2021 Table 48 Forecast Sales of Sleep Aids: Value 2021-2026 Table 49 Forecast Sales of Sleep Aids: % Value Growth 2021-2026

EYE CARE IN GREECE

KEY DATA FINDINGS

2021 DEVELOPMENTS

Increased incidence of digital eye strain drives demand in standard eye care Decrease in time spent outdoors inhibits sales of allergy eye care products PharmaSwiss Hellas continues to gain ground as Bayer enters eye care

PROSPECTS AND OPPORTUNITIES

Long-term trends will continue to drive expansion of eye care Leading brands set to face more intense competition Chemists/pharmacies will remain the dominant distribution channel

CATEGORY DATA

Table 50 Sales of Eye Care by Category: Value 2016-2021 Table 51 Sales of Eye Care by Category: % Value Growth 2016-2021 Table 52 NBO Company Shares of Eye Care: % Value 2017-2021 Table 53 LBN Brand Shares of Eye Care: % Value 2018-2021 Table 54 Forecast Sales of Eye Care by Category: Value 2021-2026 Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2021-2026

WOUND CARE IN GREECE

KEY DATA FINDINGS

2021 DEVELOPMENTS

Reduced levels of mobility continue to depress demand for wound care products Supermarkets and e-commerce gain ground at the expense of chemists/pharmacies Hansaplast loses ground to lower priced domestic brands and private label lines

PROSPECTS AND OPPORTUNITIES

Long-term declining trend set to persist throughout the forecast period Growing popularity of outdoor activities bodes well for first aid kits Further gains projected for domestic company Septona

CATEGORY DATA

Table 56 Sales of Wound Care by Category: Value 2016-2021 Table 57 Sales of Wound Care by Category: % Value Growth 2016-2021 Table 58 NBO Company Shares of Wound Care: % Value 2017-2021 Table 59 LBN Brand Shares of Wound Care: % Value 2018-2021 Table 60 Forecast Sales of Wound Care by Category: Value 2021-2026 Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2021-2026

VITAMINS IN GREECE

KEY DATA FINDINGS

2021 DEVELOPMENTS

Vitamin D shows most resilient performance in 2021 as overall demand declines E-commerce continues gaining ground at the expense of chemists/pharmacies Uni-Pharma set to consolidate its lead following multiple new launches

PROSPECTS AND OPPORTUNITIES

Overall demand will continue to wane as threat from COVID-19 recedes Vitamin D set to remain the best performing category Pace of innovation expected to drop off from 2022

CATEGORY DATA

Table 62 Sales of Vitamins by Category: Value 2016-2021 Table 63 Sales of Vitamins by Category: % Value Growth 2016-2021 Table 64 Sales of Multivitamins by Positioning: % Value 2016-2021 Table 65 NBO Company Shares of Vitamins: % Value 2017-2021 Table 66 LBN Brand Shares of Vitamins: % Value 2018-2021 Table 67 Forecast Sales of Vitamins by Category: Value 2021-2026 Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2021-2026

DIETARY SUPPLEMENTS IN GREECE

KEY DATA FINDINGS

2021 DEVELOPMENTS

Interest in products with immune system and mood/relaxing benefits remains strong Demand for probiotic supplements rebounds in 2021 Advance of e-commerce continues to erode value share of chemists/pharmacies

PROSPECTS AND OPPORTUNITIES

Several categories set to benefit from shift towards preventive and natural remedies Competition expected to intensify in an already fragmented environment Innovation and marketing activities should strengthen interest in paediatric products

CATEGORY DATA

Table 69 Sales of Dietary Supplements by Category: Value 2016-2021 Table 70 Sales of Dietary Supplements by Category: % Value Growth 2016-2021 Table 71 Sales of Dietary Supplements by Positioning: % Value 2016-2021 Table 72 NBO Company Shares of Dietary Supplements: % Value 2017-2021 Table 73 LBN Brand Shares of Dietary Supplements: % Value 2018-2021 Table 74 Forecast Sales of Dietary Supplements by Category: Value 2021-2026 Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2021-2026

WEIGHT MANAGEMENT AND WELLBEING IN GREECE

KEY DATA FINDINGS

2021 DEVELOPMENTS

Weight loss supplements remains the worst performing category in 2021 Supplement nutrition drinks proves most resilient to the impact of COVID-19 Chemists/pharmacies maintains narrow lead as gains for e-commerce continue

PROSPECTS AND OPPORTUNITIES

Declining trend expected to resume following modest recovery over 2022-2023 Weight loss supplements set to outperform meal replacement in the short term Population ageing should help to boost demand for supplement nutrition drinks

CATEGORY DATA

Table 76 Sales of Weight Management and Wellbeing by Category: Value 2016-2021 Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2016-2021 Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2017-2021 Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2018-2021 Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2021-2026 Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2021-2026

SPORTS NUTRITION IN GREECE

KEY DATA FINDINGS

2021 DEVELOPMENTS

Sports nutrition shows improved results as COVID-19 disruption begins to subside Protein/energy bars remains the best performing category E-commerce continues to gain importance in sports nutrition distribution

PROSPECTS AND OPPORTUNITIES

Impressive recovery projected for sports nutrition from 2022 Sports protein RTD set to show the fastest development Emerging threats could temper overall demand

CATEGORY DATA

Table 82 Sales of Sports Nutrition by Category: Value 2016-2021 Table 83 Sales of Sports Nutrition by Category: % Value Growth 2016-2021 Table 84 NBO Company Shares of Sports Nutrition: % Value 2017-2021 Table 85 LBN Brand Shares of Sports Nutrition: % Value 2018-2021 Table 86 Forecast Sales of Sports Nutrition by Category: Value 2021-2026 Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2021-2026

HERBAL/TRADITIONAL PRODUCTS IN GREECE

KEY DATA FINDINGS

2021 DEVELOPMENTS

Many herbal/traditional categories harder hit by COVID-19 than standard categories Herbal/traditional sleep aids shows the fastest development in 2021 Pandemic-related factors continue to depress demand in a number of categories

PROSPECTS AND OPPORTUNITIES

Outlook for herbal/traditional products remains bright overall E-commerce set to continue gaining ground Marketing strategies likely to focus on social media and point-of-sale promotions

CATEGORY DATA

Table 88 Sales of Herbal/Traditional Products by Category: Value 2016-2021 Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2016-2021 Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2017-2021 Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2018-2021 Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2021-2026 Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2021-2026

PAEDIATRIC CONSUMER HEALTH IN GREECE

KEY DATA FINDINGS

2021 DEVELOPMENTS

Reluctance to self-medicate for children continues to subdue overall demand Paediatric vitamins and dietary supplements remains buoyant despite slowdown Paediatric ibuprofen recovers as fears about COVID-19 symptoms prove unfounded

PROSPECTS AND OPPORTUNITIES

Vian expected to retain its overall lead in paediatric consumer health Paediatric vitamins and dietary supplements will remain a focal point for investment Penetration of herbal/traditional products set to continue rising

CATEGORY DATA

Table 94 Sales of Paediatric Consumer Health by Category: Value 2016-2021 Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2016-2021 Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2021 Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2017-2021 Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2018-2021 Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2021-2026 Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2021-2026